In the preamble to the rule, FDA presents a summary of its economic analyses, discussing the potential benefits of the proposed rule and the economic impact that could occur as a result of its implementation.
The preamble contains an analysis of the benefits of the rule and its effect on the economy. 
There is no preamble to the rule, the FDA neglected to draft one.